Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes
2023; American Medical Association; Volume: 9; Issue: 11 Linguagem: Inglês
10.1001/jamaoncol.2023.3759
ISSN2374-2445
AutoresOreste Gentilini, Edoardo Botteri, Claudia Sangalli, Viviana Galimberti, Mauro Porpiglia, Roberto Agresti, Alberto Luini, Giuseppe Viale, Enrico Cassano, Nickolas Peradze, Antonio Toesca, Giulia Massari, Virgilio Sacchini, Elisabetta Munzone, Maria Cristina Leonardi, Francesca Cattadori, Rosa Di Micco, Emanuela Esposito, Adele Sgarella, Silvia Cattaneo, Massimo Busani, Massimo Dessena, Anna Bianchi, Elisabetta Cretella, Francisco Ripoll Orts, Michael D. Mueller, Corrado Tinterri, Badir Jorge Chahuan Manzur, Chiara Benedetto, Paolo Veronesi, Fabio Bassi, Fulvio Borella, Pietro Caldarella, Marco Colleoni, Giovanni Corso, Silvia Dellapasqua, Alberta Ferrari, Carlos A. Garcia‐Etienne, Damiano Gentile, Alessandro Germano, L.P. Grosso, Mattia Intra, Monica Iorfida, José Vila, Gennaro Limite, Germana Lissidini, G Macellari, Francesca Magnoni, Ilaria Maugeri, Manuelita Mazza, Emilia Montagna, Paola Naninato, Luca Nicosia, Roberto Orecchia, Alberto F. Pierini, Claudia Rauh, Massimo Rinaldo, Anna Rotili, Nicole Rotmensz, Anna Rita Vento, Veronica Zuber,
Tópico(s)AI in cancer detection
ResumoSentinel lymph node biopsy (SLNB) is the standard of care for axillary node staging of patients with early breast cancer (BC), but its necessity can be questioned since surgery for examination of axillary nodes is not performed with curative intent.
Referência(s)